(Q40201943)

English

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

scientific article published on 21 June 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Angela Dispenzieri

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

7

object named as

Litzow MR

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

11

object named as

Gertz MA

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

3

object named as

Lacy MQ

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Francis K Buadi

5

object named as

Buadi FK

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

author name string

Kumar S

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Hayman SR

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Gastineau DA

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Fonseca R

8

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Roy V

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Rajkumar SV

10

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

21 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2035-2042

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Impaired PBPC collection in patients with myeloma after high-dose melphalan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Factors influencing collection of peripheral blood progenitor cells following high‐dose cyclophosphamide and granulocyte colony‐stimulating factor in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Proteasome inhibition as a novel therapeutic target in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Second autologous or allogeneic transplantation after the failure of first autograft in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

21 January 2018

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple myeloma: diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404801

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2404801

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Dimensions Publication ID

0 references

release_fvriqrxre5halklb4nxyucutui

1 reference

https://api.fatcat.wiki/v0/release/fvriqrxre5halklb4nxyucutui

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40201943&oldid=2203492437"